Effect of sodium–glucose transporter 2 inhibitor empagliflozin on proteinuria and kidney function progression in patients with non-diabetic glomerulonephritis: a pilot superiority randomized controlled trial - Hammad, Hany; Shaaban, Asmaa; Philips, Mariana Victor; Fayed, Ahmed; Abdelaziz, Tarek Samy (International urology and nephrology, 2023)
Keywords: Antidiabetics; Creatinine; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - drug therapy; Double-Blind Method; Epidermal growth factor receptors; Glomerular Filtration Rate; Glomerulonephritis; Glomerulonephritis - complications; Glomerulonephritis - drug therapy; Glucose transporter; Humans; Immunosuppression; Kidney; Kidney diseases; Medicine; Medicine & Public Health; Nephrology; Nephrology - Original Paper; Placebos; Proteinuria; Proteinuria - drug therapy; Proteinuria - etiology; Remission; Sodium-glucose cotransporter; Sodium-Glucose Transporter 2 Inhibitors - pharmacology; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Statistical analysis; Treatment Outcome; Urology; Glomerulonephritis; Empagliflozin; Sodium–glucose transporter inhibitors; Diabetes mellitus; Proteinuria